Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Joanna H. Cox & Andrea E. Cavanna. (2021) Aripiprazole for the treatment of Tourette syndrome. Expert Review of Neurotherapeutics 21:4, pages 381-391.
Read now
Read now
Felice Iasevoli, Annarita Barone, Elisabetta Filomena Buonaguro, Licia Vellucci & Andrea de Bartolomeis. (2020) Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review. Expert Opinion on Drug Safety 19:11, pages 1419-1444.
Read now
Read now
Daniel Huys, Katja Hardenacke, Pia Poppe, Christina Bartsch, Burak Baskin & Jens Kuhn. (2012) Update on the role of antipsychotics in the treatment of Tourette syndrome. Neuropsychiatric Disease and Treatment 8, pages 95-104.
Read now
Read now
Articles from other publishers (25)
Vamsi K. Kalari, Peter E. Morrison & Cathy L. Budman. 2022. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B. The Neurobiology of the Gilles De La Tourette Syndrome and Chronic Tics - Part B
203
235
.
Frank MC Besag, Michael J Vasey, Kim SJ Lao, Uttom Chowdhury & Jeremy S Stern. (2021) Pharmacological treatment for Tourette syndrome in children and adults: What is the quality of the evidence? A systematic review. Journal of Psychopharmacology 35:9, pages 1037-1061.
Crossref
Crossref
Eva-Maria Pichler, Wolfram Kawohl, Erich Seifritz & Patrik Roser. (2018) Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. The International Journal of Psychiatry in Medicine 54:2, pages 150-156.
Crossref
Crossref
Sabine Mogwitz, Judith Buse, Nicole Wolff & Veit Roessner. (2018) Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents. ACS Chemical Neuroscience 9:4, pages 651-672.
Crossref
Crossref
Alexandre Salvador, Yulia Worbe, Cécile Delorme, Giorgio Coricelli, Raphaël Gaillard, Trevor W. Robbins, Andreas Hartmann & Stefano Palminteri. (2017) Specific effect of a dopamine partial agonist on counterfactual learning: evidence from Gilles de la Tourette syndrome. Scientific Reports 7:1.
Crossref
Crossref
Sarah Gerasch, Ahmad Seif Kanaan, Ewgeni Jakubovski & Kirsten R. Müller-Vahl. (2016) Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome. Frontiers in Neuroscience 10.
Crossref
Crossref
Natalie J. Forde, Ahmad S. Kanaan, Joanna Widomska, Shanmukha S. Padmanabhuni, Ester Nespoli, John Alexander, Juan I. Rodriguez Arranz, Siyan Fan, Rayan Houssari, Muhammad S. Nawaz, Francesca Rizzo, Luca Pagliaroli, Nuno R. Zilhäo, Tamas Aranyi, Csaba Barta, Tobias M. Boeckers, Dorret I. Boomsma, Wim R. Buisman, Jan K. Buitelaar, Danielle Cath, Andrea Dietrich, Nicole Driessen, Petros Drineas, Michelle Dunlap, Sarah Gerasch, Jeffrey Glennon, Bastian Hengerer, Odile A. van den Heuvel, Cathrine Jespersgaard, Harald E. Möller, Kirsten R. Müller-Vahl, Thaïra J. C. Openneer, Geert Poelmans, Petra J. W. Pouwels, Jeremiah M. Scharf, Hreinn Stefansson, Zeynep Tümer, Dick J. Veltman, Ysbrand D. van der Werf, Pieter J. Hoekstra, Andrea Ludolph & Peristera Paschou. (2016) TS-EUROTRAIN: A European-Wide Investigation and Training Network on the Etiology and Pathophysiology of Gilles de la Tourette Syndrome. Frontiers in Neuroscience 10.
Crossref
Crossref
Wei Zheng, Xian-Bin Li, Ying-Qiang Xiang, Bao-Liang Zhong, Helen F. K. Chiu, Gabor S. Ungvari, Chee H. Ng, Grace K. I. Lok & Yu-Tao Xiang. (2016) Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis. Human Psychopharmacology: Clinical and Experimental 31:1, pages 11-18.
Crossref
Crossref
Cathy L. Budman. (2014) The Role of Atypical Antipsychotics for Treatment of Tourette’s Syndrome: An Overview. Drugs 74:11, pages 1177-1193.
Crossref
Crossref
Irene Neuner, Cornelius J. Werner, Jorge Arrubla, Tony Stöcker, Corinna Ehlen, Hans P. Wegener, Frank Schneider & N. Jon Shah. (2014) Imaging the where and when of tic generation and resting state networks in adult Tourette patients. Frontiers in Human Neuroscience 8.
Crossref
Crossref
S. Rodgers, M. Müller, W. Kawohl, D. Knöpfli, W. Rössler, E. Castelao, M. Preisig & V. Ajdacic‐Gross. (2013) Sex‐related and non‐sex‐related comorbidity subtypes of tic disorders: a latent class approach. European Journal of Neurology 21:5, pages 700.
Crossref
Crossref
Sabine Mogwitz, Judith Buse, Stefan Ehrlich & Veit Roessner. 2013. Advances in the Neurochemistry and Neuropharmacology of Tourette Syndrome. Advances in the Neurochemistry and Neuropharmacology of Tourette Syndrome
281
349
.
Stefano Palminteri & Mathias Pessiglione. 2013. Advances in the Neurochemistry and Neuropharmacology of Tourette Syndrome. Advances in the Neurochemistry and Neuropharmacology of Tourette Syndrome
131
153
.
Irene Neuner, Jorge Arrubla, Corinna Ehlen, Hildegard Janouschek, Carlos Nordt, Bruno Fimm, Frank Schneider, N Jon Shah & Wolfram Kawohl. (2012) Fine motor skills in adult Tourette patients are task-dependent. BMC Neurology 12:1.
Crossref
Crossref
Claudia Wenzel, Alexandra Kleimann, Stefanie Bokemeyer & Kirsten R. Müller-Vahl. (2012) Aripiprazole for the Treatment of Tourette Syndrome. Journal of Clinical Psychopharmacology 32:4, pages 548-550.
Crossref
Crossref
Irene Neuner, Carlos Nordt, Frank Schneider & Wolfram Kawohl. (2012) Effectiveness of aripiprazole in the treatment of adult Tourette patients up to 56 months. Human Psychopharmacology: Clinical and Experimental 27:4, pages 364-369.
Crossref
Crossref
Andrea E Cavanna, Claudia Selvini, Cristiano Termine, Chiara Luoni, Clare M Eddy & Hugh Rickards. (2011) Tolerability profile of aripiprazole in patients with Tourette syndrome. Journal of Psychopharmacology 26:6, pages 891-895.
Crossref
Crossref
Tamara Pringsheim, Asif Doja, Daniel Gorman, Duncan McKinlay, Lundy Day, Lori Billinghurst, Alan Carroll, Yves Dion, Sandra Luscombe, Thomas Steeves & Paul Sandor. (2012) Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Pharmacotherapy. The Canadian Journal of Psychiatry 57:3, pages 133-143.
Crossref
Crossref
Hanik K. Yoo, Joong-Sun Lee, Kyoung-Won Paik, Soon-Ho Choi, Sujung J. Yoon, Jieun E. Kim & Jin Pyo Hong. (2010) Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. European Child & Adolescent Psychiatry 20:3, pages 127-135.
Crossref
Crossref
. (2011) Gilles de la Tourette syndrome: the complexities of phenotype and treatment – further information. British Journal of Hospital Medicine 72:2, pages S1-S7.
Crossref
Crossref
Clare M. Eddy, Hugh E. Rickards & Andrea E. Cavanna. (2010) Treatment strategies for tics in Tourette syndrome. Therapeutic Advances in Neurological Disorders 4:1, pages 25-45.
Crossref
Crossref
Shu-Han Yu, Jen-Yu Chou, Debbie Robson & Vincent Chin-Hung Chen. (2010) Aripiprazole for the tic symptoms in a child receiving atomoxetine treatment for ADHD. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:7, pages 1355-1356.
Crossref
Crossref
Yong-hua CuiYi ZhengYun-ping YangJing LiuJun Li. (2010) Effectiveness and Tolerability of Aripiprazole in Children and Adolescents with Tourette's Disorder: A Pilot Study in China. Journal of Child and Adolescent Psychopharmacology 20:4, pages 291-298.
Crossref
Crossref
David Vidal & Jordi Mestres. (2010) In Silico Receptorome Screening of Antipsychotic Drugs. Molecular Informatics 29:6-7, pages 543-551.
Crossref
Crossref
Kendra Lewis, Leonard Rappa, Devon A. Sherwood-Jachimowicz & Margareth Larose-Pierre. (2010) Aripiprazole for the Treatment of Adolescent Tourette’s Syndrome. Journal of Pharmacy Practice 23:3, pages 239-244.
Crossref
Crossref